Results with homoharringtonine (HHT) alone or with cytosine arabinoside (ara-C) in late chronic phase chronic myelogenous leukemia (CML) (p =.02).
| Parameter . | HHT . | HHT plus ara-C . |
|---|---|---|
| No. treated | 73 | 100 |
| %CHR | 67 | 72 |
| % cytogenetic response | 30 | 32 |
| - major | 15 | 15 |
| - complete | 5 | 5 |
| % 4-year survival | 38 | 58 |
| Abbreviations: CHR, complete hematologic response | ||
| Parameter . | HHT . | HHT plus ara-C . |
|---|---|---|
| No. treated | 73 | 100 |
| %CHR | 67 | 72 |
| % cytogenetic response | 30 | 32 |
| - major | 15 | 15 |
| - complete | 5 | 5 |
| % 4-year survival | 38 | 58 |
| Abbreviations: CHR, complete hematologic response | ||